GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
Adding Oncolytics Biotech Inc. (ONCY) $1.02 to 2025 Watch List.
The Oncolytics Biotech Inc. (ONCY) idea is coming from one of our top 'tipsters' the Big Wig - whose two previous ideas, Allarity (ALLR)...
We’re Up 118% on Allarity (ALLR) Today.
Since adding Allarity (ALLR) to the Watch List at $0.70, we are up 194%, and that ain't bad - for exactly 4 months and...
GeoVax Report (GOVX) $0.69. From Crystal Research.
July 2025 Update on GeoVax Labs, Inc. (GOVX-NASDAQ)
Crystal Research Associates has issued a 16-page Company Update on clinical-stage biotechnology company, GeoVax Labs, Inc. (GOVX-NASDAQ).
Snapshot...
GeoVax (GOVX) Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen...
https://youtu.be/4LffUyg6yE8?si=G8_kZMce8yHGCxKp
GEO-CM04S1 Offers Solution to Overcome HHS-Cited mRNA Deficiencies - Potentially Offering Broader, More Durable Protection
ATLANTA, GA - August 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs,...
Compass Pathways (CMPS) $4.44, Gains 85% Since Adding to Watch List.
Down from $56.95 - But Up from $2.36. Woo hoo!
Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36
We are probably...
Our 4th Billion Dollar Takeover! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding to...
Two Doubles, From the Same Stock!
Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go...
Vystar (VYST)$0.16. While Shares not yet Actively Trading, Gains 54% From Adding to Watch...
World's Best Air Purifier, FDA Cleared (Medical), Gets a Boost.
(Just to be clear, this is not your everyday $200 Walmart air cleaner, using HEPA...
Latest article
Fusion Energy Starter.
VC-Funded Fusion Energy Companies
"The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...
Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.
I. No Bells, No Baskets. UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!
II. Replimune (REPL) $11.23. Gains 28% in Sympathy with...
We’re Up 360% in Six Weeks. Replimune (REPL).
That's a Gain of $604 Million, and That Ain't Bad!
Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...
